as on September 13, 2025 at 1:29 am IST
Day's Low
Day's High
0.39%
Downside
5.97%
Upside
52 Week's Low
52 Week's High
57.60%
Downside
6.58%
Upside
Check Bridgebio Pharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$9.8B
EPS (TTM)
-2.7404
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-10.2
Industry PE ratio
10.127857142857144
P/B Ratio
0PEG Ratio
0EBITDA
-623.7M
Revenue (TTM)
235.8M
Profit Margin
0.00%
Return On Equity TTM
64478700.00%
Track how Bridgebio Pharma Inc P/E has moved over time to understand its valuation trends.
Bridgebio Pharma Inc in the last 5 years
Lowest (0.00x)
September 13, 2025
Today (-10.20x)
September 13, 2025
Industry (10.13x)
September 13, 2025
Highest (0.00x)
September 13, 2025
Today’s Price to Earnings Ratio: -10.20x
Compare market cap, revenue, PE, and other key metrics of Bridgebio Pharma Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $9.8B | 56.73% | -10.2 | 0.00% | |
BUY | $61.1B | 280.5% | -505.15 | -12.96% | |
NA | $37.7B | NA | NA | -3.89% | |
BUY | $101.2B | 54.04% | 28.08 | 31.86% | |
BUY | $59.4B | 2.03% | 14.11 | 31.37% |
The Bridgebio Pharma Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Bridgebio Pharma Inc investment value today
Current value as on today
₹2,00,823
Returns
₹1,00,823
(+100.82%)
Returns from Bridgebio Pharma Inc Stock
₹95,684 (+95.68%)
Dollar Returns*
₹5,139 (+5.14%)
Based on 20 analysts
85.00%
Buy
15.00%
Hold
0.00%
Sell
Based on 20 analysts, 85% of analysts recommend a 'BUY' rating for Bridgebio Pharma Inc. Average target price of $64.6
Get share price movements and forecasts by analysts on Bridgebio Pharma Inc.
What analysts predicted
20.7%UPSIDE
Target Price
$64.6
Current Price
$51.23
Analyzed by
20 Analysts
Target
$64.60
Bridgebio Pharma Inc target price $64.6, a slight upside of 20.7% compared to current price of $51.23. According to 20 analysts rating.
Search interest for Bridgebio Pharma Inc Stock has increased by 86% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:86% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 03 September
Wed, 04:40 PM
-H.C. Wainwright also maintains Buy rating, increasing price target from $56 to $70, with all analysts rating it Buy.
Wed, 05:11 PM
-J.P. Morgan maintains Buy rating on BridgeBio, raising price target to $70, citing strong pipeline and product launch.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 3 Years
In the last 3 years, BBIO has outperformed top 5 stocks with highest market-cap in its industry
Best in 1 Year
In the last 1 year, BBIO has outperformed top 5 stocks with highest market-cap in its industry
Revenue Fall
Revenue is down for the last 2 quarters, 116.63M → 110.56M (in $), with an average decrease of 5.2% per quarter
Price Dip
In the last 7 days, BBIO stock has moved down by -5.6%
Profit Down
Netprofit is down for the last 2 quarters, -167.42M → -181.90M (in $), with an average decrease of 8.7% per quarter
Organisation | Bridgebio Pharma Inc |
Headquarters | 3160 Porter Drive, Palo Alto, CA, United States, 94304 |
Industry | Health Technology |
CEO | Dr. Neil Kumar Ph.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. Richard H. Scheller Ph.D. | Chairman of Research & Development |
Mr. Eli M. Wallace Ph.D. | Chief Scientific Officer of Oncology |
Dr. Eric Michael David J.D., M.D., Ph.D. | Chief Executive Officer of Gene Therapy |
Dr. Charles J. Homcy M.D. | Co-Founder, Chairman of Pharmaceuticals & Independent Lead Director |
Ms. Maricel M. Apuli | Chief Accounting Officer |
Dr. Frank P. McCormick Ph.D. | Co-Founder, Chairman of Oncology & Director |
Dr. Uma Sinha Ph.D. | Chief Scientific Officer |
Mr. Matthew Outten CPC, MBA | Chief Commercial Officer |
Dr. Neil Kumar Ph.D. | Co-Founder, CEO & Director |
Dr. Thomas Trimarchi Ph.D. | CFO & President |
Bridgebio Pharma Inc share price today is $51.23 as on at the close of the market. Bridgebio Pharma Inc share today touched a day high of $54.29 and a low of $51.03.
Bridgebio Pharma Inc share touched a 52 week high of $54.6 on and a 52 week low of $21.72 on . Bridgebio Pharma Inc stock price today i.e. is closed at $51.23,which is 6.17% down from its 52 week high and 135.87% up from its 52 week low.
Bridgebio Pharma Inc market capitalisation is $0.01T as on .
Indian investors can start investing in Bridgebio Pharma Inc (BBIO) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Bridgebio Pharma Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Bridgebio Pharma Inc share’s latest price of $51.23 as on September 13, 2025 at 1:29 am IST, you will get 0.1952 shares of Bridgebio Pharma Inc. Learn more about
fractional shares .
Bridgebio Pharma Inc stock has given 56.73% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?